MyFinsight
Home
Blog
About
Cash and cash
equivalents
$10,332,520
(-16.41%↓ Y/Y)
Accounts and other
receivable
$228,051
(-20.47%↓ Y/Y)
Prepaid expenses and
other current assets
$219,707
(95.02%↑ Y/Y)
Total current assets
$10,780,278
(-15.52%↓ Y/Y)
Intangible asset, net
$1,901,797
(-5.05%↓ Y/Y)
Long-term deposits
$39,120
(-3.97%↓ Y/Y)
Total assets
$12,721,195
(-14.07%↓ Y/Y)
Total liabilities and
shareholders' equity
$12,721,195
(-14.07%↓ Y/Y)
Total shareholders'
equity
$8,811,154
(-37.65%↓ Y/Y)
Total current
liabilities
$3,910,041
(481.27%↑ Y/Y)
Accumulated deficit
-$77,896,367
(-22.39%↓ Y/Y)
Accumulated other
comprehensive loss
-$158,541
(-28.81%↓ Y/Y)
Authorized unlimited
common shares without...
$62,416,047
(15.01%↑ Y/Y)
Accounts payable and
accrued liabilities
$3,910,041
(481.27%↑ Y/Y)
Additional paid-in capital
$16,037,835
(11.32%↑ Y/Y)
Preferred stock, shares
issued-Series B1Preferred...
$7,208,266
(-11.75%↓ Y/Y)
Preferred stock, shares
issued-Series A1Preferred...
$1,203,914
(14.14%↑ Y/Y)
Back
Back
Balance Sheet
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA)
source: myfinsight.com